Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda

Direct‐acting antivirals for hepatitis C virus (HCV) are highly effective and well‐tolerated. However, only a small percentage of HCV‐infected individuals globally have received therapy. Reducing the complexity of monitoring during HCV therapy, if shown to be safe, could facilitate greater access to...

Descripción completa

Detalles Bibliográficos
Autores principales: Grant, Philip, Shumbusho, Fabienne, Van Nuil, Jennifer Ilo, Kateera, Fredrick, Mukherjee, Joia, Kabahizi, Jules, Ntaganda, Fabien, Nsanzimana, Sabin, Mbituyumuremyi, Aimable, Damascene, Makuza Jean, Muvunyi, Claude Mambo, Mukabatsinda, Constance, Musabeyezu, Emmanuel, Ntirenganya, Cyprien, Gupta, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109339/
https://www.ncbi.nlm.nih.gov/pubmed/32258951
http://dx.doi.org/10.1002/hep4.1482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109339/
https://www.ncbi.nlm.nih.gov/pubmed/32258951
http://dx.doi.org/10.1002/hep4.1482

Ejemplares similares